» Articles » PMID: 27145047

Allergic Bronchopulmonary Aspergillosis is Associated with Pet Ownership in Cystic Fibrosis

Overview
Specialty Pediatrics
Date 2016 May 5
PMID 27145047
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Late diagnosis of allergic bronchopulmonary aspergillosis (ABPA) is associated with significant lung function decline and morbidity in cystic fibrosis (CF). The association of ABPA and domestic pet ownership in patients with CF has not been elucidated yet. Our objective was to determine the association of ABPA with pet ownership in patients with CF.

Methods: Clinical and microbiological data from certified local patient registry were analyzed for 109 patients with CF aged 1-64 years: 55 pet owner and 54 non-pet owners. The primary outcome of the retrospective observational study was the occurrence of ABPA in pet owners and non-pet owners with CF. The free statistical software R was utilized to investigate logistic regression models for association factors.

Results: Of the 109 patients included in the study, 61 (56%) were female. The mean age of the total group was 25.4 ± 13.2 years. Adjusted analysis revealed that ABPA (OR 5.0227, 95% CI: 1.182-21.340, p = 0.029) was associated with pet ownership in patients with CF. Furthermore, ABPA in pet owners with CF was associated with an increased number of exacerbations (OR 6.446, 95% CI: 1.057-39.328, p = 0.043). Other outcomes did not significantly differ.

Conclusion: Owning a pet was associated with ABPA in patients with CF. Future prospective multicenter longitudinal studies are needed to investigate chronological causality between pet ownership, ABPA development, and pulmonary exacerbations and to determine whether these estimates are generalizable for ABPA susceptible patients beyond CF (asthma, bronchiectasis).

Citing Articles

The Association of Chronic Pulmonary Aspergillosis and Chronic Pulmonary Histoplasmosis with MDR-TB Patients in Indonesia.

Soeroso N, Siahaan L, Khairunnisa S, Anggriani R, Aida A, Eyanoer P J Fungi (Basel). 2024; 10(8).

PMID: 39194855 PMC: 11355089. DOI: 10.3390/jof10080529.


Fungal Colonization of the Airways of Patients with Cystic Fibrosis: the Role of the Environmental Reservoirs.

Ravenel K, Guegan H, Gastebois A, Bouchara J, Gangneux J, Giraud S Mycopathologia. 2024; 189(2):19.

PMID: 38407729 DOI: 10.1007/s11046-023-00818-x.


Emerging Fungal Threats in Cystic Fibrosis.

Schwarz C, Eschenhagen P, Bouchara J Mycopathologia. 2021; 186(5):639-653.

PMID: 34319568 DOI: 10.1007/s11046-021-00574-w.


Frequent Pet Contact as Risk Factor for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.

Grehn C, Eschenhagen P, Temming S, Duesberg U, Neumann K, Schwarz C Front Cell Infect Microbiol. 2021; 10:601821.

PMID: 33585274 PMC: 7873990. DOI: 10.3389/fcimb.2020.601821.


Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation.

Renner S, Nachbaur E, Jaksch P, Dehlink E J Fungi (Basel). 2020; 6(4).

PMID: 33371198 PMC: 7766476. DOI: 10.3390/jof6040381.